Understanding Biosimilars in Healthcare Settings
Explore the evolving role of biosimilars in healthcare settings and delve into key concepts such as transitioning to biosimilars, interchangeability, and practical considerations for clinical practice. Learn about legislative, regulatory, and operational factors influencing biosimilar adoption. Target audience includes Pharmacists, Pharmacy Technicians, Nurses, and Dietitians.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
Accreditation Statement In support of improving patient care, the National Home Infusion Association (NHIA) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designations This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credit for learning and change.
Overview, Target Audience, and Learning Objectives PURPOSE PURPOSE: The purpose of this CE activity is: As biosimilars continue to expand their footprint in healthcare, their role in home and alternate site settings is becoming increasingly significant. With a growing number of biosimilars available and interchangeable options emerging, this session explores what the future holds for these innovative therapies. This session will delve into key concepts such as transitioning from parent products to biosimilars, understanding interchangeability, and addressing practical considerations for their use in clinical practice. Learners will gain valuable insights into the legislative, regulatory, and operational factors shaping biosimilar adoption in these care settings. TARGET AUDIENCE TARGET AUDIENCE: The professional audience for which this CE activity has been designed includes Pharmacists, Pharmacy Technicians, Nurses, and Dietitians. LEARNING OBJECTIVES LEARNING OBJECTIVES: The learning objectives for this activity are as follows: Review the legislative impact for pharmacies as it relates to interchangeability of approved molecules in clinical practice. Review current requirements for FDA approval of biosimilars and interchangeability requirements for biosimilars. Describe potential processes to overcome barriers to biosimilar adoption (prescribing, financial, operational).
Disclosure of Relevant Financial Relationships As an accredited provider of continuing education for the healthcare team, NHIA collects disclosure of financial relationships with all ineligible companies, which include manufacturers of drugs, medical equipment, and other products related to patient care. All relevant financial relationships have been mitigated prior to the start of this activity.
Disclosure of Relevant Financial Relationships (continued) The following are the relevant financial relationships from planners, faculty, reviewers, or other persons that affect the content of this activity: All persons who affect the content of this webinar have reported no relevant financial relationships.
